国药现代：维生素B6注射液获得药品补充申请批准通知书

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (国药容生), has received approval from the National Medical Products Administration for a supplemental application regarding Vitamin B6 injection, allowing for an increase in specifications and passing the consistency evaluation for generic drug quality and efficacy [1] Group 1 - The approved Vitamin B6 injection is indicated for the prevention and treatment of Vitamin B6 deficiency, management of isoniazid poisoning, and can also be used for nausea caused by pregnancy, radiation sickness, and chemotherapy, as well as seborrheic dermatitis [1] - The injection is also used for total parenteral nutrition and supplementation in cases of nutritional deficiency due to inadequate intake, as well as for progressive weight loss situations [1] - Additional indications include situations requiring increased Vitamin B6 intake and congenital Vitamin B6 dependency syndrome in newborns [1]